An Analysis of NICE Technology Appraisal Decisions ‘Recommended in Line with Clinical Practice’

Aurea Duran;Nancy Devlin;Phill O’Neill;Amanda Cole

Grant-Funded Research from Office of Health Economics

Abstract: Between January 2007 and June 2016 nearly a quarter (89 of 407) of all National Institute for Health and Care Excellence (NICE)-reported decisions for individual technologies assessed through their technology appraisal (TA) process have been characterised by them as recommended in line with clinical practice (RiLCP), to be distinguished from recommended in line with marketing authorisation. These RiLCP decisions are counted as ‘recommended’ in NICE statistics summarising technology appraisal (TA) decision outcomes, and 44% percent (89 of 203) of all ‘recommended’ decisions in the period 2007-2016 are given this classification. The objectives of this study are twofold: First, we qualitatively assess documentation associated with RiLCP decisions to create a framework to describe common themes and criteria used to reach those decisions. Second, we assess the level of patient access associated with each RiLCP decision using a previously developed method – the ‘M’ score.

Keywords: An; Analysis; of; NICE; Technology; Appraisal; Decisions; ‘Recommended; in; Line; with; Clinical; Practice’ (search for similar items in EconPapers)
JEL-codes: I1 (search for similar items in EconPapers)
Date: 2016-12-01
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.ohe.org/publications/analysis-nice-tec ... rch-report-final-v2/ (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ohe:grafun:001777

Access Statistics for this paper

More papers in Grant-Funded Research from Office of Health Economics Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).